
Tlando Oral Capsules Reduce IBD Flare-Ups in American Males: A 3-Year Study
Reading Time: 3 minutes Introduction Inflammatory Bowel Disease (IBD), encompassing conditions such as Crohn’s disease and ulcerative colitis, remains a significant health concern among American males. The chronic nature of IBD necessitates continuous management and exploration of therapeutic options that can alleviate symptoms and improve quality of life. Recent research has turned its focus toward Tlando, an oral testosterone replacement therapy, and its potential effects on gastrointestinal health. This article delves into a three-year study examining the influence of Tlando oral capsules on IBD in American males, offering insights into its potential as a therapeutic adjunct. Study Design and Methodology The study was conducted...